Imamura M, Prasad A, Prasad C
Department of Medicine, Louisiana State University Medical Center, New Orleans 70112, USA.
Life Sci. 1998;63(16):1461-8. doi: 10.1016/s0024-3205(98)00413-5.
Numerous studies have documented a role for enterostatins in appetitive behavior. However, due to the lack of knowledge about the distribution of enterostatins in tissues and body fluids, it has not been possible to examine the role of endogenous enterostatin in this process. To this end, using a polyclonal antibody raised against enterostatin -- Val-Pro-Asp-Pro-Arg (VPDPR), we examined the nature and distribution of enterostatin-like immunoreactivity in the rat urine by ELISA and chromatography. The results reported here show for the first time the presence of VPDPR-like immunoreactivity (VPDPR-LI) in rat urine. Further characterization of rat urine VPDPR-LI revealed that it is not due to VPDPR but to another peptide similar to VPDPR. Furthermore, as urinary excretion of corticosterone increases, the level of VPDPR-LI in urine decreases.
许多研究都记录了肠抑胃素在食欲行为中的作用。然而,由于对肠抑胃素在组织和体液中的分布缺乏了解,因此无法研究内源性肠抑胃素在此过程中的作用。为此,我们使用针对肠抑胃素——缬氨酸-脯氨酸-天冬氨酸-脯氨酸-精氨酸(VPDPR)制备的多克隆抗体,通过酶联免疫吸附测定法(ELISA)和色谱法检测了大鼠尿液中肠抑胃素样免疫反应性的性质和分布。此处报道的结果首次显示大鼠尿液中存在VPDPR样免疫反应性(VPDPR-LI)。对大鼠尿液VPDPR-LI的进一步表征表明,它并非源于VPDPR,而是源于另一种与VPDPR相似的肽。此外,随着皮质酮尿排泄量增加,尿液中VPDPR-LI的水平会降低。